Early life administration of Bifidobacterium bifidum BD-1 alleviates long-term colitis by remodeling the gut microbiota and promoting intestinal barrier development

Inflammatory bowel disease (IBD) is a chronic intestinal disease characterized by microbiota disturbance and intestinal mucosal damage. The current study aimed to investigate the preventive effects of Bifidobacterium bifidum BD-1 (BD-1) against long-term IBD and possible mechanism by which it alters...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Chenrui, Li, Jinxing, Miao, Zhonghua, Wang, Yunyi, Wu, Simou, Wang, Yimei, Wang, Silu, Cheng, Ruyue, He, Fang, Shen, Xi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355606/
https://www.ncbi.nlm.nih.gov/pubmed/35935215
http://dx.doi.org/10.3389/fmicb.2022.916824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355606/
https://www.ncbi.nlm.nih.gov/pubmed/35935215
http://dx.doi.org/10.3389/fmicb.2022.916824

Ejemplares similares